BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3535840)

  • 1. Should vitamin C supplementation be restricted in regular hemodialysis patients?
    Ono K; Hisasue Y; Morimatsu M
    ASAIO Trans; 1986; 32(1):111-3. PubMed ID: 3535840
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of vitamin C supplementation and withdrawal on the mortality and morbidity of regular hemodialysis patients.
    Ono K
    Clin Nephrol; 1989 Jan; 31(1):31-4. PubMed ID: 2914408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients.
    Pru C; Eaton J; Kjellstrand C
    Nephron; 1985; 39(2):112-6. PubMed ID: 3974772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbic acid aggravates secondary hyperoxalemia in patients on chronic hemodialysis.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Haubenstock A
    Ann Intern Med; 1984 Sep; 101(3):344-5. PubMed ID: 6465702
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients.
    Ono K
    Clin Nephrol; 1986 Nov; 26(5):239-43. PubMed ID: 3802587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients.
    Fumeron C; Nguyen-Khoa T; Saltiel C; Kebede M; Buisson C; Drüeke TB; Lacour B; Massy ZA
    Nephrol Dial Transplant; 2005 Sep; 20(9):1874-9. PubMed ID: 15972322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbic acid depletion in patients undergoing chronic hemodialysis.
    Sullivan JF; Eisenstein AB
    Am J Clin Nutr; 1970 Oct; 23(10):1339-46. PubMed ID: 4990916
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
    Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
    Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis.
    Rolton HA; McConnell KM; Modi KS; Macdougall AI
    Nephrol Dial Transplant; 1991; 6(6):440-3. PubMed ID: 1876286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation.
    Böhm V; Tiroke K; Schneider S; Sperschneider H; Stein G; Bitsch R
    Int J Vitam Nutr Res; 1997; 67(4):262-6. PubMed ID: 9285256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial calcinosis associated with hemodialysis.
    Zazgornik J; Balcke P; Biesenbach G; Kaiser W; Stockenhuber F
    Am J Cardiol; 1987 Aug; 60(4):421-2. PubMed ID: 3618514
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of vitamin C supplementation on serum uric acid in patients undergoing hemodialysis: a randomized controlled trial.
    Biniaz V; Tayebi A; Ebadi A; Sadeghi Shermeh M; Einollahi B
    Iran J Kidney Dis; 2014 Sep; 8(5):401-7. PubMed ID: 25194408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ascorbic acid supplementation on plasma isoprostanes in haemodialysis patients.
    Chan D; Irish A; Croft KD; Dogra G
    Nephrol Dial Transplant; 2006 Jan; 21(1):234-5. PubMed ID: 16204285
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin C neglect in hemodialysis: sailing between Scylla and Charybdis.
    Handelman GJ
    Blood Purif; 2007; 25(1):58-61. PubMed ID: 17170539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress.
    Yang CC; Hsu SP; Wu MS; Hsu SM; Chien CT
    Kidney Int; 2006 Feb; 69(4):706-14. PubMed ID: 16395251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment.
    Weissinger EM; Nguyen-Khoa T; Fumeron C; Saltiel C; Walden M; Kaiser T; Mischak H; Drüeke TB; Lacour B; Massy ZA
    Proteomics; 2006 Feb; 6(3):993-1000. PubMed ID: 16372263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin C deficiency in dialysis patients--are we perceiving the tip of an iceberg?
    Handelman GJ
    Nephrol Dial Transplant; 2007 Feb; 22(2):328-31. PubMed ID: 17107966
    [No Abstract]   [Full Text] [Related]  

  • 18. Antioxidant treatment in dialysis patients- importance of ferritin.
    Ersoy A
    Nephrol Dial Transplant; 2006 Jul; 21(7):2035-6. PubMed ID: 16504978
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipoprotein oxidation profile in end stage renal disease patients. Role of vitamin C supplementation].
    Ramos R; Gómez-Geriqué N; Martínez-Castelao A
    Nefrologia; 2005; 25(2):178-84. PubMed ID: 15912655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The excretion of ascorbic acid and its metabolites in uremia and hemodialysis].
    Bakaev VV; Efremov AV
    Patol Fiziol Eksp Ter; 2000; (2):22-4. PubMed ID: 10846906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.